Savara’s Persistence May Pay Off In Rare Lung Disease

 
• By Joseph Haas
  
Alveoli
Savara is trying to bring a first approved drug for a rare alveoli disorder • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D